+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2020

  • ID: 5004201
  • Clinical Trials
  • February 2020
  • Region: Global
  • 104 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Alvotech ehf
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Johnson & Johnson
  • MORE
Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2020

Summary

This clinical trial report, “Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2020" provides an overview of Hidradenitis Suppurativa Clinical trials scenario. This report provides top line data relating to the clinical trials on Hidradenitis Suppurativa. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. The clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AbbVie Inc
  • Alvotech ehf
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Johnson & Johnson
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Hidradenitis Suppurativa Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Hidradenitis Suppurativa
  • Nov 19, 2019: XBiotech announces rapid enrollment for its randomized multi-center clinical study for Bermekimab in patients with Hidradenitis Suppurativa
  • Nov 07, 2019: InflaRx reports positive results from the open label extension part of the SHINE study for IFX-1 in Hidradenitis Suppurativa
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Publisher
  • Contact Us
  • Source
List of Tables
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
List of Figures
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2020*
  • Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • Report Methodology
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AbbVie Inc
  • Novartis AG
  • Johnson & Johnson
  • Pfizer Inc
  • UCB SA
  • XBiotech Inc
  • Amgen Inc
  • Bristol-Myers Squibb Co
  • Abbott Laboratories
  • Alvotech ehf
Note: Product cover images may vary from those shown
Adroll
adroll